Decade after $8B deal, Roche offloads InterMune to mysterious specialty pharma

Roche’s $8 billion InterMune acquisition, disclosed a decade ago, is now being handed to a specialty pharmaceutical company.

Cayman Islands-based Legacy Pharma is run by …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Signal: Moderna mRNA patent revoked by EPO after Pfizer suit – Pharmaceutical Technology

Share this article The Moderna dispute revolved around Pfizer and BioNTech’s Comirnaty vaccine. Photo: Md Rafayat Haque Khan/Eyepix Group/Future Publishing via Getty Images. Moderna‘s decision

November 22, 2023

Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation – Biotech Investments

EQS-News: Biotest AG / Key word(s): Research Update Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation 28.11.2023

November 29, 2023

IRA lawsuits will test US’ ability to regulate social pricing in pharma – Pharmaceutical Technology

Share this article The Department of Health and Human Services headquarters, Washington, D.C. Photo: Christopher E Zimmer / Shutterstock.com. Lawsuits brought by a range of

January 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.